Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms

Daniel Kepple; Colby T Ford; Jonathan Williams; Beka Abagero; Shaoyu Li; Jean Popovici; Delenasaw Yewhalaw; Eugenia Lo

doi:10.1371/journal.pntd.0011926

. 2024 Jan 29;18(1):e0011926. doi: 10.1371/journal.pntd.0011926

Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms

Daniel Kepple ^1,^*, Colby T Ford ^2,³, Jonathan Williams ¹, Beka Abagero ¹, Shaoyu Li ⁴, Jean Popovici ⁵, Delenasaw Yewhalaw ^6,⁷, Eugenia Lo ^1,^8,^*

Editor: Ananias A Escalante⁹

¹Biological Sciences, University of North Carolina, Charlotte, North Carolina, United States of America

²Bioinformatics and Genomics, University of North Carolina, Charlotte, North Carolina, United States of America

³School of Data Science, University of North Carolina, Charlotte, North Carolina, United States of America

⁴Mathematics and Statistics, University of North Carolina, Charlotte, North Carolina, United States of America

⁵Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia

⁶Tropical and Infectious Diseases Research Center, Jimma University, Jimma, Ethiopia

⁷School of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma University, Jimma, Ethiopia

⁸Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, Pennsylvania, United States of America

⁹Temple University, UNITED STATES

The authors have declared that no competing interests exist.

^✉

* E-mail: dkepple@uncc.edu (DK); el855@drexel.edu (EL)

Roles

Daniel Kepple: Conceptualization, Data curation, Formal analysis, Methodology, Resources, Writing – original draft, Writing – review & editing

Colby T Ford: Conceptualization, Data curation, Formal analysis, Methodology, Resources, Writing – original draft

Jonathan Williams: Data curation, Formal analysis, Methodology, Writing – original draft

Beka Abagero: Data curation, Formal analysis, Methodology, Resources, Writing – original draft

Shaoyu Li: Data curation, Formal analysis, Methodology, Resources, Writing – original draft

Jean Popovici: Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Resources, Writing – original draft

Delenasaw Yewhalaw: Conceptualization, Data curation, Formal analysis, Methodology, Resources, Writing – original draft

Eugenia Lo: Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing

Ananias A Escalante: Editor

PMCID: PMC10901308 PMID: 38285730

Abstract

The documentation of Plasmodium vivax malaria across Africa especially in regions where Duffy negatives are dominant suggests possibly alternative erythrocyte invasion mechanisms. While the transcriptomes of the Southeast Asian and South American P. vivax are well documented, the gene expression profile of P. vivax in Africa is unclear. In this study, we examined the expression of 4,404 gene transcripts belong to 12 functional groups and 43 erythrocyte binding gene candidates in Ethiopian isolates and compared them with the Cambodian and Brazilian P. vivax transcriptomes. Overall, there were 10–26% differences in the gene expression profile amongst geographical isolates, with the Ethiopian and Cambodian P. vivax being most similar. Majority of the gene transcripts involved in protein transportation, housekeeping, and host interaction were highly transcribed in the Ethiopian isolates. Members of the reticulocyte binding protein PvRBP2a and PvRBP3 expressed six-fold higher than Duffy binding protein PvDBP1 and 60-fold higher than PvEBP/DBP2 in the Ethiopian isolates. Other genes including PvMSP3.8, PvMSP3.9, PvTRAG2, PvTRAG14, and PvTRAG22 also showed relatively high expression. Differential expression patterns were observed among geographical isolates, e.g., PvDBP1 and PvEBP/DBP2 were highly expressed in the Cambodian but not the Brazilian and Ethiopian isolates, whereas PvRBP2a and PvRBP2b showed higher expression in the Ethiopian and Cambodian than the Brazilian isolates. Compared to Pvs25, gametocyte genes including PvAP2-G, PvGAP (female gametocytes), and Pvs47 (male gametocytes) were highly expressed across geographical samples.

Author summary

Plasmodium vivax malaria is a neglected tropical disease, despite being more geographically widespread than any other form of malaria and causes 132–391 million clinical infections each year. The documentation of P. vivax infections in different parts of Africa where Duffy-negative individuals, who were previously thought to be immune to P. vivax malaria, are dominant suggested that there are alternative pathways for P. vivax to invade human erythrocytes. Experimental approaches to unveil parasite invasion ligands are greatly limited due to a lack of reliable long-term culturing techniques and thus remains largely unexplored. Findings of this study are the first to examine the transcriptomes of African P. vivax and compare such to other geographical isolates with the goal to provide an important baseline for future comparisons of P. vivax transcriptomes in Duffy-negative infections. Our analyses also highlight potential biomarkers for improved gametocyte detection to better monitor the spread of P. vivax malaria.

1. Introduction

Plasmodium vivax Duffy binding protein (PvDBP1), which binds to the cysteine-rich region II of the human glycoprotein Duffy Antigen-Chemokine Receptor (DARC) [1–3], was previously thought to be the exclusive invasion mechanism for P. vivax [4]. However, the several reports of P. vivax infections in majority Duffy-negative countries [3] have raised important questions of how P. vivax invades erythrocytes. It was previously hypothesized that either mutations in PvDBP1 or a weakened expression of DARC in Duffy-negative individuals allowed P. vivax invasion in Duffy-negative erythrocytes [5,6] and thus enabled P vivax to spread in Africa. Despite mutational differences observed in PvDBP1 between Duffy-positive and Duffy-negative infections, these differences do not lead to binding of Duffy-negative erythrocytes [4] and suggested alternative invasion pathways.

Plasmodium vivax is closely related to a large clade of malaria parasites that infect lesser apes and ceropithecoids (old world monkeys) of Southeast Asia [7,8]. The exact origin of human P. vivax is still heavily debated, with evidence of P. vivax originating in Africa [7] and in Asia [9,10] both being supported. The first reference genome of P. vivax was Salvador I, isolated from Saimiri boliviensis monkeys in El Salvador in 2008 [11], followed by the P01 genome isolated from a P. vivax patient in Indonesia in 2016 [12]. The P. vivax nuclear genome is 29 megabases with a 39.8% G-C composition and 6,642 genes distributed amongst 14 chromosomes [12]. Several large gene subfamilies have been identified in the P01 genome, including the most abundant Plasmodium interspersed repeat (pir; formally described as vir) genes in the subtelomeric region, followed by unclassified Plasmodium exported proteins and tryptophan-rich antigen proteins [12]. Remarkably, across the genome, approximately 77% of genes are orthologous between P. falciparum, P. knowlesi, and P. yoelii [11]. Genes involved in key metabolic pathways, housekeeping functions, and membrane transporters are highly conserved between P. vivax and P. falciparum [11]. However, P. vivax isolates from Africa, Southeast Asia, South America, and Pacific Oceania have significantly higher nucleotide diversity at the genome level compared to P. falciparum [13,14], likely due to variations in transmission intensity, frequency of gene flow via human movement, age of host-pathogen interactions, and host susceptibility [15].

Genes such as erythrocyte binding protein (PvEBP), reticulocyte binding protein (PvRBP), merozoite surface protein (PvMSP), apical membrane antigen 1 (PvAMA1), anchored micronemal antigen (PvGAMA), Rhoptry neck protein (PvRON), and tryptophan-rich antigen genes (PvTRAg) families are suggested to play a role in erythrocyte invasion [13,16], especially in low-density infections [17–21]. Prior genomic studies have shown high polymorphisms in genes such as PvDBP1, PvMSP1, PvMSP7, and PvRBP2c [22–26]. Erythrocyte binding protein gene, PvEBP, a paralog of PvDBP1, harbors all the hallmarks of a Plasmodium red blood cell invasion protein. PvEBP is similar to PcyM DBP2 sequences in P. cynomolgi and contains a Duffy-binding like domain [27]. Binding assay of PvEBP region II (171–484) showed moderate binding activity to Duffy-negative erythrocytes [4]. Both PvDBP1 and PvEBP (PvDBP2) genes exhibit high genetic diversity and are common antibody binding targets associated with clinical protection [28,29]. Host receptors for both PvRBP1b and PvRBP1a proteins remain undetermined, but several members of PvRBP2 (PvRBP2a, PvRBP2b, PvRBP2c, PvRBP2d, PvRBP2e, PvRBP2p1, and PvRBP2p2) are orthologous to PfRH2a, PcyRBP2, and PfRH2b, with PvRBP2a and PfRh5 share high structural similarity [30,31]. PvRBP2b and PvRBP2c are orthologous to PcyRBP2b and PcyRBP2c, respectively [32]. The receptor for PvRBP2a was previously identified as CD98, a type II transmembrane protein that links to one of several L-type amino acid transporters to form heterodimeric neutral amino acid transport systems [33]; the receptor for PvRBP2b is transferrin receptor 1 (TfR1) [34]. The PvRBP2b-TfR1 interaction plays a critical role in reticulocyte invasion in Duffy-positive infections [34]. MSP1 also shows a strong binding affinity, with high-activity binding peptides (HABPs) clustered close to these two fragments at positions 280–719 and 1060–1599, respectively [35], suggesting a critical role in erythrocyte invasion. Although the MSP7 gene family shows no binding potential, it forms a complex with PvTRAg36.6 and PvTRAg56.2 on the surface, likely for stabilization purposes at the merozoite surface [20]. A comparison of P. vivax transcriptomes between Aotus and Saimiri monkeys indicated that the expression of six PvTRAg genes in Saimiri P. vivax was 37-fold higher than in the Aotus monkey strains [19], five of which bind to human erythrocytes [20,36]. Although most TRAg receptors remain poorly characterized and unnamed, the receptor of PvTRAg38 has been identified as Band 3 [37].

Recent advance in short-term in vitro culturing and schizont-enrichment methodologies have enabled transcriptomic sequencing of P. vivax enabling a comprehensive review of stage-specific gene expression profile and structure, of which thousands of splices and unannotated untranslated regions were characterized [38]. The transcriptomes of Cambodian [39] and Brazilian [40] P. vivax field isolates showed high expression levels and large populational variation amongst host-interaction transcripts. For example, the MSP1 gene family was highly upregulated in the Cambodian P. vivax compared to the Brazilian ones. Similar trends were also observed in PvDBP1, PvEBP, PvMA, PvRA, PvRBP2a, PvMSP5, and PvMSP4, highlighting geographical differences in the gene expression profile. In P. falciparum, distinct phenotypic and expression levels of erythrocyte binding antigen (EBA) and reticulocyte binding-like homologue (Rh) gene families were observed among geographical isolates due to varying immunogenic pressures [41]. Heterogeneity of gene expression has been documented amongst P falciparum-infected samples, implying that the parasites can modulate the gene transcription process through epigenetic regulation [42]. However, the transcriptomic profile of African P. vivax remains unexplored, and it is unclear if there is heterogeneity among the continental isolates. In addition, our previous study found that two CPW-WPC genes PVP01_0904300 and PVP01_1119500 expressed in the male gametocytes, and Pvs230 (PVP01_0415800) and ULG8 (PVP01_1452800) expressed in the female gametocytes were highly expressed relative to Pvs25 in the Ethiopian P. vivax [43]. While these genes have a potential to be used for gametocyte detection, it remains unclear if such expressional patterns are similar in other geographical isolates.

In this study, we aimed to 1) examine the overall gene expression profile of 10 Ethiopian P. vivax with respect to different intraerythrocytic lifecycle stages; 2) determine the expression levels of previously characterized erythrocyte binding gene candidates [13]; 3) compare gene expression profiles of the Ethiopian P. vivax with the Cambodian [39] and Brazilian [40] isolates from in vitro especially on the erythrocyte binding and male/female gametocyte gene candidates. These findings are the first to describe P. vivax transcriptomes from East Africa and provide critical insights into alternative parasite invasion ligand proteins other than PvDBP1. A systematic comparison of gene expression profiles among the African, Southeast Asian, and South American isolates will deepen our understanding of P. vivax transcriptional machinery and invasion mechanisms.

2. Materials and methods

2.1 Ethics statement

Scientific and ethical clearance was obtained from the institutional scientific and ethical review boards of Jimma University, Ethiopia (#03-246-796-22) and University of North Carolina at Charlotte, USA (IRBIS-21-0371). Written informed consent/assent for study participation was obtained from all consenting heads of households, parents/guardians (for minors under 18 years old), and individuals who were willing to participate in the study.

2.2 Sample preparation

Ten microscopy-confirmed P. vivax samples were collected from Duffy positive patients at hospitals in Jimma, Ethiopia. These patients had 4,000 parasites/μL parasitemia and had not received prior antimalarial treatment. A total of 10mL whole blood was preserved in sodium heparin tubes at the time of collection. Red blood cell pellets were isolated and cryo-preserved with two times glycerolyte 57 and stored in liquid nitrogen within one hour of collection. Prior to culture, samples were thawed by adding 0.2V of 12% NaCl solution drop-by-drop followed by a 5-minute room temperature incubation. Ten-times volume of 1.6% NaCl solution was then added drop-by-drop to the mixture and the samples were centrifuged at 1000 rcf for 10 minutes to isolate the red blood cell pellet. This process was repeated with a 10x volume of 0.9% NaCl. Following centrifugation, the supernatant was removed via aspiration, and 18mL of sterile IMDM (also containing 2.5% human AB plasma, 2.5% HEPES buffer, 2% hypoxanthine, 0.25% albumax, and 0.2% gentamycin) per 1mL cryo-preserved cell mixture was added to each sample for a final hematocrit of 2%. 10% Giemsa thick microscopy slides were made to determine the majority parasite stage and duration of incubation required; being 20–22 hours for the majority trophozoites and 40–44 hours for the majority ring to ensure samples were majority schizont for future analysis. Samples were incubated at 37°C in a 5% O2, 5% CO2 with the same infected patient blood in situ to allow maturation and minimize potential culturing effects of the transcriptome. In vitro maturation was validated through microscopic smears 20–40 hours after the initial starting time, dependent on the majority stage. To minimize oxidative stress, each culture was checked more than two times and returned to a 5% oxygen environment immediately after checking.

Cultured pellets were isolated via centrifugation and placed in 10x volume trizol for RNA extraction. RNA extraction was performed using direct-zol RNA prep kit according to the manufacturer’s protocol, followed by two rounds of DNA digestion using the DNA-free kit (Zymo). Samples were analyzed with a nanodrop 2000 and RNA Qubit to ensure sample concentrations were above 150 ng total for library construction. For samples with no significant amount of DNA or protein contaminants, RNA libraries were constructed using Illumina rRNA depletion library kits according to the manufacturer’s protocol. Completed libraries were quality checked using a bioanalyzer to ensure adequate cDNA was produced before sequencing. Sample reads were obtained using Illumina HiSeq 2x150bp configuration to obtain at least 35 million reads per sample. Sequence reads were aligned with HISAT2 [44], using the Rhisat2 R package [45] to the P01 P. vivax reference genome and all human reads were filtered out using SAMtools [46] (implemented in the R package [47]). The alignment was mapped to the P01 reference annotation using the Rsubread package [48].

2.3 Data analyses

To further confirm samples were majority schizont stage, sequence reads of each sample were deconvoluted in CIBERSORTx [49] based on P. berghei homologs [50]. We used the published matrix to determine the frequency of expression for each gene calculated for rings, trophozoites, and schizonts, respectively. Transcripts that were expressed 30% or more were sorted into their respective stages. All reads were annotated using the Rsubread package and classified into 12 different categories by function. We then examined the top 30 transcribed genes using the counts per million (CPM) metric.

Our previously published whole genome sequence data identified several mutations and structural polymorphisms in genes from the PvEBP, PvRBP, PvMSP, and PvTRAg gene families that are likely to involve in erythrocyte invasion [13]. Specific binding regions in some of the genes such as PvDBP1, PvEBP/DBP2, PvRBP2b, and PvMSP3 have been identified [51]. To further explore the putative function, we compared relative expression levels of 43 erythrocyte binding gene candidates (S1 Table) in the 10 Ethiopian P. vivax samples with other geographical isolates that were of majority schizont stage. We used the CPM and TPM (transcripts per million) metrics in R package edgeR [52]. The CPM metric was used to obtain the top 30 transcripts overall and does not consider gene length, while TPM considers gene length for normalization and allows an unbiased conclusion to be made relative between and to other transcriptomes [40]. We then transformed the data using log(2)TPM+1 to illustrate relative expression levels via a heat map with an average abundance. We also selected 25 gametocyte gene candidates, 15 of which were shown to correlate to female gametocyte development and nine to male gametocytes [43,53], to assess their expression levels relative to the standard Pvs25 in the samples. In addition, we examined the expression of AP2-G that is a critical transcription factor for both male and female gametocyte development [54].

2.4 Comparison of datasets

Previously published, raw RNA-seq data of four in vitro Cambodian [39] and two in vitro Brazilian [40] P. vivax samples were downloaded from the GitHub repositories and analyzed with the same bioinformatic methods described above to minimize potential batch effects. The Ethiopian P. vivax samples were cultured and sequenced using the same media and timelines (being majority schizont prior to RNA collection) as the Cambodian [39] and Brazilian [40] isolates. To further ensure comparisons are accurate and unbiased, we deconvoluted the parasite stages using the same matrix and found no statistical difference in the average stage composition. We then obtained the average expression and standard deviation in TPM for each gene target and determined potential difference in transcription levels by conducting pairwise differential expression (DE) analysis among the Cambodian, Brazilian, and Ethiopian samples. The expression level of 6,829 genes were examined for DE by edgeR dream [52,55] and variancePartition [56], with adjusted p-value<1.0e-6 for DE gene concordance. A linear mixed effects models was used to ensure accuracy in triplicated Brazilian samples, and the Kenward-Roger method was used to estimate the effective degree of freedom for hypothesis testing due to small sample sizes.

3. Results

3.1 Overview of the Ethiopian P. vivax transcriptomes

Based on deconvolution, all 10 Ethiopian P. vivax samples had similar proportions of trophozoite and schizont stage (Fig 1A). Only less than 1% of the sequence reads belong to the ring stage. Microscopic results corroborated the deconvolution analyses showing similar proportion of parasite stages in a subset of samples (Fig 1B). The deconvolution of P. vivax sequence reads from the Cambodian and Brazilian samples also showed no significant difference in the proportions of trophozoites or schizonts (P>0.05; Fig 1A).

Overall, about 64% (4,404 out of 6,830) of the genes were detected with transcription in the Ethiopian P. vivax. Of the 4,404 genes, 69% (2,997) were annotated with known functions and 31% (1,407 genes) remain uncharacterized (Fig 2A). We normalized each sample expression profile to TPM to remove technical bias in the sequences and ensure gene expressions were directly comparable within and between samples. Of the 2,997 genes with known function, 21.7% are responsible for housekeeping, and 14.2% genes for post-translation modifications (PTMs) and regulation. The PIR proteins account for 4.8% (212) of all the identified genes and ~2.8% of the genes are involved in host-pathogen interactions. Nearly 52% of all detectable transcripts (2,288 genes) were expressed at a threshold of 20 TPM or above, which were considered as highly transcribed (Fig 2B). These highly transcribed transcripts showed similar proportions of gene categories including unknown, PTM/regulatory, DNA regulation, replication/elongation, host interactions, cell signaling, and resistance. Only transcripts involved in transport and housekeeping showed a slight increase of 2.9% and 1.48%, respectively, indicating a higher activity relative to the other categories. By contrast, transcripts involved in RNA regulation, PIR, and ribosomal activity showed a slight decrease of 2.19%, 1.79%, and 1.71%, indicating an overall lower activity compared to other categories (Fig 2B).

Fig 2 — Categorization of (A) all detectable transcripts and (B) upregulated (TPM > 20) transcripts for the Ethiopian P. *vivax* by gene function. The numbers shown represent the number of transcripts along with the overall percentage compared to all detected transcripts. Transcripts that were not detected were removed from the analysis. Only transcripts involved in transport and housekeeping showed a slight increase of 2.9% and 1.48%, respectively in the number of upregulated transcripts, indicating a higher activity relative to the other categories. By contrast, transcripts involved in RNA regulation, PIR, and ribosomal activity showed a slight decrease of 2.19%, 1.79%, and 1.71%, indicating an overall lower activity compared to other categories.

3.2 Top 30 transcripts of Ethiopian P. vivax

For the 10 Ethiopian P. vivax transcriptomes, four genes including PVP01_1000200 (PIR protein), PVP01_0202900 (18s rRNA), PVP01_0319600 (RNA-binding protein), and PVP01_0319500 (unknown function) were the most highly expressed among the others (Fig 3). Transcripts involved in housekeeping and PTM regulation each account for 23.3% of the top 30 highly expressed genes. Among genes involved in host-interactions, PVP01_0715400 (merozoite organizing protein), PVP01_0816800 (protein RIPR), PVP01_1402400 (reticulocyte binding protein 2a), and PVP01_1469400 (reticulocyte binding protein 3) are highly expressed. Five gene transcripts including PVP01_1000200 from the PIR family, PVP01_0319500 of unknown function, PVP01_0202900 a 18S rRNA, PVP01_1329600 a putative glutathione S-transferase, and PVP01_0418800 a putative pentafunctional AROM polypeptide showed most variable expression levels among the 10 samples, with a standard deviation of 20,000 and higher CPM (Fig 3). Three other genes including PVP01_0202700 (28S ribosomal RNA), PVP01_1137600 (basal complex transmembrane protein 1), PVP01_1243600 (replication factor C subunit 3) showed moderate variation ranging from 1,397 to 1,033 CPM. All other genes such as PVP01_1206500 (elongation factor Tu) and PVP01_1011500 (an unclassified protein) showed consistent expression level with variation under 1,000 CPM among samples (Fig 3).

Fig 3 — Genes are arranged by different functions as indicated on the y-axis. Overall, four genes including PVP01_1000200 (PIR protein), PVP01_0202900 (18s rRNA), PVP01_0319600 (RNA-binding protein), and PVP01_0319500 (unknown function) from four different functional groups were shown to be most highly expressed among the others. Of interest, PVP01_0715400 (merozoite organizing protein), PVP01_0816800 (protein RIPR), PVP01_1402400 (reticulocyte binding protein 2a), and PVP01_1469400 (reticulocyte binding protein 3) were among the top 30 highly expressed genes involved in host interactions.

3.3 Differentially expressed genes among geographical P. vivax

The overall gene expression profile was similar between the Ethiopian and Cambodian P. vivax, but different from the Brazilian ones (Fig 4A and S2 Table). Several genes involved in DNA regulation, host-interactions, replication, ribosomal, and transportation were upregulated in the Ethiopian and Cambodian isolates but showed considerable downregulation in Brazilian ones. Based on the Kenward-Roger DE analyses, a total of 1,831 differentially expressed genes were detected between the Cambodian and Brazilian isolates (CvB), 1,716 between the Ethiopian and Brazilian (EvB), and 721 between the Ethiopian and Cambodian (EvC) isolates (Fig 4B–4D). The EvC analysis showed the lowest differentiation with only 10.6% of the entire transcriptome (Fig 4B), while EvB and CvB showed a greater differentiation of 25.1% and 26.8%, respectively (Fig 4C and 4D). For the 721 genes that were differentially expressed between the Cambodian and Ethiopian P. vivax, nearly half of them were significantly upregulated in Ethiopia compared to Cambodia (Fig 4B). Four genes including PVP01_0208700 (V-type proton ATPase subunit C), PVP01_0102800 (chitinase), PVP01_0404000 (PIR protein), and PVP01_0808300 (zinc finger (CCCH type protein) showed low levels of transcription (log₁₀P-value>50; Fig 4B) compared to other DE genes. By contrast, two genes including PVP01_1329600 (glutathione S-transferase) and PVP01_MIT03400 (cytochrome b) were highly transcribed (log₂fold change>10). For the 1,716 genes that were differentially expressed between the Ethiopian and Brazilian P. vivax, 914 of them were highly transcribed (Fig 3C). Of these, three genes including PVP01_1412800 (M1-family alanyl aminopeptidase), PVP01_0723900 (protein phosphatase-beta), and PVP01_0504500 (28S ribosomal RNA) showed a log₁₀P-value greater then 75, indicating substantial expressional differences. For the 1,831 genes that were differentially expressed between the Cambodian and Brazilian P. vivax, 948 of them were highly transcribed (Fig 4D). Four genes including PVP01_1005900 (ATP-dependent RNA helicase DDX41), PVP01_0318700 (tRNAHis guanylyltransferase), PVP01_1334600 (60S ribosomal protein L10), and PVP01_1125300 (SURP domain-containing protein) showed substantial expressional differences with log₁₀P-value greater than 75. Two genes, PVP01_0010550 (28S ribosomal RNA) and PVP01_0422600 (early transcribed membrane protein), were shown with low expression (log₁₀fold change<-12), while one gene PVP01_0901000 (PIR protein) with substantial expression (log₁₀fold change>12). These comparisons further demonstrated the differences in transcriptional patterns between geographical isolates.

3.4 Expression of genes related to erythrocyte invasion

Of the 43 candidate genes associated with erythrocyte binding function, PvDBP1 on average showed about 10-fold higher expression than PvEBP/DBP2, which showed very low expression in four of the Ethiopian P. vivax samples (Fig 5). PvRBP2b showed four-fold higher expression than PvEBP/DBP2, but 50% less than PvDBP1. PvRBP2a showed consistently the highest expression across all samples, with about 6-fold, 67-fold, and 15-fold higher expression than PvDBP1, PvEBP/DBP2, and PvRBP2b, respectively. Other genes including PvMSP3.8, PvTRAg14, and PvTRAg22 also showed higher expression than PvDBP1. Of the 15 PvTRAg genes, only PvTRAg14 and PvTRAg22 showed expression higher than PvDBP1; PvTRAg23 and PvTRAg24 showed the lowest expression. Other putatively functional ligands including PvRA and PvRON4 showed 7–10 times lower expression compared to PvDBP1, though PvGAMA, PvRhopH3, PvAMA1, and PvRON2 were expressed higher than PvEBP/DBP2.

Fig 5 — *PvRBP*2b showed four-fold higher expression on average than *PvEBP/DBP*2, but 50% less than *PvDBP*1. *PvRBP*2a showed consistently the highest expression across all samples, with about 6-fold, 67-fold, and 15-fold higher expression than *PvDBP*1, *PvEBP/DBP*2, and *PvRBP*2b, respectively. Other genes including *PvMSP*3.8, *PvTRAg*14, and *PvTRAg*22 also showed higher expression than *PvDBP*1.

We further compared the expressional pattern of these 43 genes in the Ethiopian P. vivax with the Cambodian and Brazilian isolates (Fig 6). Members of the PvDBP and PvRBP gene family showed generally higher expression in the Cambodian P. vivax than the other isolates (Fig 6A). For instance, the expression of PvDBP1, PvRBP1a, and PvRBP1b were significantly higher in the Cambodian than the other isolates (P<0.01), whereas PvRBP2a and PvRBP2b showed higher expression in the Ethiopian P. vivax than the others. Compared to the PvDBP and PvRBP gene families, the expression patterns of PvMSP were different (Fig 6B). Most of the MSP gene members including PvMSP3.5, PvMSP3.11, and PvMSP4 showed substantially higher expression in the Brazilian P. vivax than the other isolates (P<0.01). Only PvMSP3.8 of the 12 PvMSP genes was expressed significantly higher in the Ethiopian than the others (P<0.01; Fig 6B). Of the 16 PvTRAg genes, PvTRAg14 and PvTRAg22 showed significantly higher expression in the Ethiopian isolates compared to the others (P<0.05; Fig 6C). Eight other members including PvTRAg2b, PvTRAg7, PvTRAg19, PvTRAg20, PvTRAg21, PvTRAg23, PvTRAg24, and PvTRAg38 showed significantly higher expression in the Brazilian isolates than the others (P<0.05; Fig 6C). The remaining nine putatively functional ligands showed relatively similar expression levels, except for PvMA, PvRhopH3, and PvTrx-mero that were highly expressed in the Brazilian isolates (P<0.05; Fig 6D).

3.5 Expression of female and male gametocyte genes

Based on the expression level of Pvs25 (PvP01_0616100), all 10 Ethiopian P. vivax samples contained submicroscopic gametocytes, in addition to the four samples from Cambodia and two samples from Brazil (Fig 7). Amongst the 26 gametocyte-related genes, PvAP2-G (PVP01_1440800) as well as the gametocyte associated protein, GAP (PVP01_1403000) and Pvs47 (PVP01_1208000) from female and male gametocytes, respectively, showed the highest expression across the Ethiopian, Cambodian, and Brazilian isolates, and were consistently higher than Pvs25 (Fig 7). This expression pattern suggests the potential utility of these three genes as better gametocyte biomarkers across geographical isolates. Other genes indicated differential expression patterns among isolates, e.g., the female gametocyte gene PVP01_0904300 (CPW-WPC family protein) showed consistently high levels of expression in both the Ethiopian and Cambodian isolates, though much lower in the Brazilian ones. On the other hand, PVP01_1302200 (high mobility group protein B1) and PVP01_1262200 (fructose 1,6-bisphosphate aldolase) from the female and male gametocytes showed the highest expression levels in Brazilian P. vivax but not the Ethiopian and Cambodian ones.

Fig 7 — Based on the expression level of *Pvs25*, all 10 *in vitro P*. *vivax* samples from Ethiopia, four samples from Cambodia, and two samples from Brazil contained gametocytes. Three genes, PVP01_1440800 (*PvAP2-G*), PVP01_1403000 (gametocyte associated protein, GAP), and PVP01_1208000 (*Pvs47*) from female and male gametocytes, respectively, showed the highest expression across all geographical isolates, and were consistently higher than *Pvs25*.

4. Discussion

This study is the first to examine the transcriptomic profile of P. vivax from Africa and compare gene expression among geographical isolates. Approximately 32% of the detected transcripts are of unknown function, some of which such as PVP01_0319500, PVP01_1011500, and PVP01_1228800 were among the highest expressed and could play critical function. It is not surprising that 23% of the highly expressed transcripts belong to housekeeping function, such as several zinc fingers and ATP-synthase proteins. Besides, there is a large number of highly expressed protein regulators and PTMs that have not been thoroughly examined. For example, PVP01_1444000, a ubiquitin-activating enzyme, was among the highest expressed transcripts but with unclear function. Several other protein kinases, lysophospholipases, and chaperones were also highly expressed but their role in intercellular signaling pathways is unclear. It is worth noting that a great proportion of transcripts responsible for ribosomal protein production were highly expressed compared to other gene categories. These ribosomal proteins support intraerythrocytic development of the parasites from one stage to another.

Members of the RBP family including PvRBP1a, PvRBP2a, PvRBP2b, and PvRBP3 were consistently highly expressed across the Ethiopian and Cambodian but not the Brazilian isolates, suggestive of potential differences in their role of erythrocyte invasion. Recent studies showed that the binding regions of PvRBP1a and PvRBP1b are homologous to that of PfRh4, and the amino acids at site ~339–599 were confirmed to interact with human reticulocytes [57]. Though the host receptors of both PvRBP1a and PvRBP1b proteins are unclear, their receptors are neuraminidase resistant [31]. Recently, transferrin receptor 1 (TfR1) has been identified as the receptor for PvRBP2b and the PvRBP2b-TfR1 interaction plays a critical role in reticulocyte invasion in Duffy-positive infections [34]. PvRBP2d, PvRBP2e, and PvRBP3 are pseudogenes that share homology with other PvRBPs but encode for nonfunctional proteins [58]. The extent to which of these PvRBP genes involve, if any, in erythrocyte invasion remains unclear and requires functional assays in broad samples. The high expression of PvRBP genes in Ethiopia could be related to a greater proportion of individuals having low levels of DARC expression (i.e., Duffy-negatives) [3], where P. vivax can infect and adapt to both Duffy-positive and Duffy-negative populations [59]; whereas in Cambodia and the inland regions of Brazil, populations are predominantly Duffy-positive [3]. Given that P. falciparum can modulate gene expression in response to their hosts through epigenetic regulation [42,60,61], higher PvRBP expression in the Ethiopian P. vivax could be a response to the host Duffy phenotype. Further investigation on the expression and binding affinity of these PvRBP genes in different Duffy groups is necessary.

Another invasion protein, RIPR, was also among the highly expressed transcripts in P. vivax. RIPR is currently known as a vaccine target in P. falciparum [62], where RIPR (PfRH5) binds to the erythrocyte receptor basigin [63,64]. The PfRh5 complex is composed of PfRh5, Ripr, CyRPA, and Pf113, which collectively promote successful merozoite invasion of erythrocytes by binding to basigin (BSG, CD147) [64,65]. A BSG variant on erythrocytes, known as Ok^a-, has been shown to reduce merozoite binding affinities and invasion efficiencies [63], though this has only been reported in individuals of Japanese ancestry [66]. Despite the clear role of RIPR in P. falciparum, P. vivax RIPR does not seem to bind to BSG [67] and the exact role of RIPR and its binding target(s) remains unclear.

The KR-DE analysis showed 10–26% variation among the transcriptomes of the three countries, with the Ethiopian and Cambodian P. vivax being most similar whereas the Cambodian and Brazilian P. vivax most different. Genes that showed the highest levels of differentiation were those involved in housekeeping, PIR, and ribosomal functions. The exact reason for such differences amongst the geographical P. vivax isolates remains unclear. Earlier whole genome sequencing analyses indicated clear genetic distinction between Southeast Asian and South/Central American P. vivax populations [68]. P. vivax from East Africa (Madagascar and Mauritania) was closely related to the Indian isolates and intermediate between the clades of Asia and the Americas. More recent study including broader African samples indicated that the Ethiopian, Cambodian, and Brazilian P. vivax are independent subpopulations, with isolates from Southeast Asia and East Africa share common ancestry [69]. Microsatellite analyses of global P. vivax further showed that the South American P. vivax were more related to the Asian populations while the Central American P. vivax were more closely related to some African populations [67], suggesting a recent introduction of P. vivax from Asia and Africa into America. These genetic relationships may reflect the ancient connections between African and Asian (Old World) P. vivax populations and suggest that Asian P. vivax populations may have genetically mingled with the American (New World) lineages to a limited extent in recent times and explain variations in the expression profiles. Alternatively, in P. falciparum, host nutrition has been shown to significantly alter gene expression related to housekeeping, metabolism, replication, and invasion/transmission [70]. A prior study has shown malnourishment can offer a protective effect to P. vivax infections in people from the western Brazilian Amazon [71], though it remains uncertain if this could contribute to genetic relationships observed. In zebra fish, sex determination can cause significant expressional differences in the housekeeping genes [72], suggesting that sexual development factors may alter expression profiles. Technical differences between the study sites, such as cryopreservation and schizont maturation techniques used in Ethiopia and Brazil, or the small presence of ring-stage parasites identified in Brazilian isolates, may alter expression profiles, though to what degree remains uncertain. Future studies with expanded geographical samples are needed to draw more definitive conclusions. Additionally, studies comparing expression profiles of cryopreserved and fresh parasite ex-vivo short-term cultures would validate the results of this study.

P. vivax PIR genes support a wide range of functions, including antigenic variation, immune evasion, sequestration, and adhesion [73,74]. Gene expression studies suggested their prominent role in virulence and chronic infections. In P. berghei, the pir transcriptional repertoire is diverse with different members or subfamilies expressed at different time throughout the parasite developmental cycle [75]. PIR proteins have been shown to be targeted by antibodies [76]. The high expression observed for some PIR proteins, such as PVP01_1000200, in the Cambodian and Ethiopian P vivax may suggest the prominent role of VIR antigens in epigenetic regulation associated with host exposure and immune responses [42,60,61], and such immune responses could vary in diverse geographical settings [77–79]. Varying expression of ribosomal proteins, such as PVP01_0827400 (60S ribosomal protein L26) and PVP01_1013900 (40S ribosomal protein S9, putative) may be attributed to host nutrition, which is directly proportional to the speed of replication in P. berghei [70]. Future studies should examine host factors associated with the expression of these genes in P. vivax.

In this study, the deconvolution of stage-specific transcripts was based on the P. berghei orthologues rather than the single-cell RNA-seq data of P. vivax because the latter did not show expression from the ring stage. To date, P. berghei remains the most comprehensively characterized single-cell data for both sexual and asexual blood stages of Plasmodium [80,81], and their orthologues have been shown to be reliable for determining stage-specific transcripts [53]. In primates, most P vivax genes have been shown to transcribe during a short period in the intraerythrocytic cycle [82] with a high proportion of late-schizont transcripts expressed as early as the trophozoite stage. In P. berghei, the process of gametocyte development and genes involve in sequestration are transcribed much earlier during the trophozoite-schizont transition stage. Male gametocyte development precursors are expressed in the asexual stages prior to the onset of gametocyte development [83,84]. For example, the transcription factor AP2-G in P. vivax expresses early in the asexual stage for parasites that are committed to sexual development [54]. These factors hinder deconvolution efforts, making it challenging to identify which genes are transcribed in each stage precisely. Future studies should consider combining in vivo (rich in ring and trophozoites) and in vitro (rich in trophozoites and schizonts) RNA-seq data to provide a more comprehensive and reliable stage-specific model for deconvolution.

Low density P. vivax gametocytes in asymptomatic carriers can significantly contribute to transmission [85,86]. In areas with low transmission, submicroscopic infections are hidden reservoirs for parasites with high proportions of infectious gametocytes [87]. The current gametocyte biomarkers Pvs25 (PVP01_0616100) and Pvs16 (PVP01_0305600) account only for female gametocytes [88], and grossly underestimate the total gametocyte densities. We previously described two alternative female (PVP01_0415800 and PVP01_0904300) and one male (PVP01_1119500) gametocyte genes that show higher expression than Pvs25 in the Ethiopian isolates [43]. Nevertheless, these genes showed relatively low expression in the Cambodian and Brazilian isolates. By contrast, PvAP2-G (PVP01_1440800), GAP (PVP01_1403000), and Pvs47 (PVP01_1208000) were moderately expressed across all geographical isolates, and at a level higher than Pvs25. Thus, these genes warrant further investigations on their potential utility as gametocyte biomarkers in low-density infections, as well as their exact role in gametocyte development.

5. Conclusion

This paper characterized the first P. vivax transcriptome from the African isolates and identified several host-interaction gene transcripts, including PvRBP2a, PvMSP3.8, PvTRAg14, and PvTRAg22 that were highly expressed compared to PvDBP1 in parasites from human populations where Duffy negativity is rare or absent. We further demonstrated 10% to 26% differences in the gene expression profile amongst the geographical isolates, with the Ethiopian and Cambodian P. vivax being most similar. These findings provide an important baseline for future comparisons of P. vivax transcriptomes with Duffy-negative infections. Further investigations examining binding affinity and functionality of P. vivax ligands, especially PvRBP2a, PvMSP3.8, PvTRAg14, and PvTRAg22 are imperative to clarify their role in erythrocyte invasion. Furthermore, PVP01_1440800 (PvAP2-G), PVP01_1403000 (GAP), and PVP01_1208000 (Pvs47) of both female and male gametocytes showed higher expression than the standard Pvs25 in all geographical P. vivax. These gene markers may provide better gametocyte detection for low-density infections.

Supporting information

S1 Table. Name and gene ID of 43 candidate invasion genes.

(XLSX)

pntd.0011926.s001.xlsx^{(9.4KB, xlsx)}

S2 Table

Kenward-Roger DE analyses comparing the differentially expressed genes between (a) Ethiopian and Cambodian, (b) Ethiopian and Brazilian, and (c) Cambodian and Brazilian P. vivax.

(XLSX)

pntd.0011926.s002.xlsx^{(417.1KB, xlsx)}

Acknowledgments

We thank the field team from Jimma University for their technical assistance; the communities and hospitals for their support and willingness to participate in this research; and undergraduate students at UNC Charlotte for assistance with the experiments.

Data Availability

Sequences for the 10 Ethiopian transcriptomes are available on the National Center for Biotechnology Information Short Read Archive under BioProject: PRJNA784582. All code is available on GitHub at https://github.com/colbyford/vivax_transcriptome_comparisons.

Funding Statement

This research was funded by National Institutes of Health R01 AI162947 to E.L and R01 AI173171 to E.L. and J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1.Chitnis CE, Miller LH. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med. 1994;180(2):497–506. doi: 10.1084/jem.180.2.497 [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Fang XD, Kaslow DC, Adams JH, Miller LH. Cloning of the Plasmodium vivax Duffy receptor. Mol Biochem Parasitol. 1991;44(1):125–32. doi: 10.1016/0166-6851(91)90228-x [DOI] [PubMed] [Google Scholar]
3.Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, et al. The global distribution of the Duffy blood group. Nat Commun. 2011;2:266. doi: 10.1038/ncomms1265 [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Gunalan K, Lo E, Hostetler JB, Yewhalaw D, Mu J, Neafsey DE, et al. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proc Natl Acad Sci U S A. 2016;113(22):6271–6. doi: 10.1073/pnas.1606113113 [DOI] [PMC free article] [PubMed] [Google Scholar]
5.Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A. 2010;107(13):5967–71. doi: 10.1073/pnas.0912496107 [DOI] [PMC free article] [PubMed] [Google Scholar]
6.Menard D, Chan ER, Benedet C, Ratsimbasoa A, Kim S, Chim P, et al. Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains. PLoS Negl Trop Dis. 2013;7(11):e2489. doi: 10.1371/journal.pntd.0002489 [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Escalante AA, Cepeda AS, Pacheco MA. Why Plasmodium vivax and Plasmodium falciparum are so different? A tale of two clades and their species diversities. Malar J. 2022;21(1):139. doi: 10.1186/s12936-022-04130-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Luo Z, Sullivan SA, Carlton JM. The biology of Plasmodium vivax explored through genomics. Ann N Y Acad Sci. 2015;1342:53–61. doi: 10.1111/nyas.12708 [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Rougeron V, Boundenga L, Arnathau C, Durand P, Prugnolle F. The origin of Plasmodium vivax: science or story telling? FEMS Microbiol Rev. 2022;46(4). [DOI] [PubMed] [Google Scholar]
10.Daron J, Boissiere A, Boundenga L, Ngoubangoye B, Houze S, Arnathau C, et al. Population genomic evidence of Plasmodium vivax Southeast Asian origin. Sci Adv. 2021;7(18). doi: 10.1126/sciadv.abc3713 [DOI] [PMC free article] [PubMed] [Google Scholar]
11.Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008;455(7214):757–63. doi: 10.1038/nature07327 [DOI] [PMC free article] [PubMed] [Google Scholar]
12.Auburn S, Bohme U, Steinbiss S, Trimarsanto H, Hostetler J, Sanders M, et al. A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes. Wellcome Open Res. 2016;1:4. doi: 10.12688/wellcomeopenres.9876.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
13.Ford A, Kepple D, Abagero BR, Connors J, Pearson R, Auburn S, et al. Whole genome sequencing of Plasmodium vivax isolates reveals frequent sequence and structural polymorphisms in erythrocyte binding genes. PLoS Negl Trop Dis. 2020;14(10):e0008234. doi: 10.1371/journal.pntd.0008234 [DOI] [PMC free article] [PubMed] [Google Scholar]
14.White MT, Shirreff G, Karl S, Ghani AC, Mueller I. Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria. Proc Biol Sci. 2016;283(1827):20160048. doi: 10.1098/rspb.2016.0048 [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Auburn S, Benavente ED, Miotto O, Pearson RD, Amato R, Grigg MJ, et al. Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics. Nat Commun. 2018;9(1):2585. doi: 10.1038/s41467-018-04965-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Roesch C, Popovici J, Bin S, Run V, Kim S, Ramboarina S, et al. Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion. PLoS Negl Trop Dis. 2018;12(10):e0006555. doi: 10.1371/journal.pntd.0006555 [DOI] [PMC free article] [PubMed] [Google Scholar]
17.Arevalo-Pinzon G, Bermudez M, Curtidor H, Patarroyo MA. The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes. Malar J. 2015;14:106. doi: 10.1186/s12936-015-0619-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
18.Baquero LA, Moreno-Perez DA, Garzon-Ospina D, Forero-Rodriguez J, Ortiz-Suarez HD, Patarroyo MA. PvGAMA reticulocyte binding activity: predicting conserved functional regions by natural selection analysis. Parasit Vectors. 2017;10(1):251. doi: 10.1186/s13071-017-2183-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
19.Gunalan K, Sa JM, Moraes Barros RR, Anzick SL, Caleon RL, Mershon JP, et al. Transcriptome profiling of Plasmodium vivax in Saimiri monkeys identifies potential ligands for invasion. Proc Natl Acad Sci U S A. 2019;116(14):7053–61. doi: 10.1073/pnas.1818485116 [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Tyagi K, Hossain ME, Thakur V, Aggarwal P, Malhotra P, Mohmmed A, et al. Plasmodium vivax Tryptophan Rich Antigen PvTRAg36.6 Interacts with PvETRAMP and PvTRAg56.6 Interacts with PvMSP7 during Erythrocytic Stages of the Parasite. PLoS One. 2016;11(3):e0151065. doi: 10.1371/journal.pone.0151065 [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Wang B, Lu F, Cheng Y, Chen JH, Jeon HY, Ha KS, et al. Correction for Wang et al., "Immunoprofiling of the Tryptophan-Rich Antigen Family in Plasmodium vivax". Infect Immun. 2018;86(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
22.Chen SB, Wang Y, Kassegne K, Xu B, Shen HM, Chen JH. Whole-genome sequencing of a Plasmodium vivax clinical isolate exhibits geographical characteristics and high genetic variation in China-Myanmar border area. BMC Genomics. 2017;18(1):131. doi: 10.1186/s12864-017-3523-y [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Cornejo OE, Fisher D, Escalante AA. Genome-wide patterns of genetic polymorphism and signatures of selection in Plasmodium vivax. Genome Biol Evol. 2014;7(1):106–19. doi: 10.1093/gbe/evu267 [DOI] [PMC free article] [PubMed] [Google Scholar]
24.Diez Benavente E, Ward Z, Chan W, Mohareb FR, Sutherland CJ, Roper C, et al. Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure. PLoS One. 2017;12(5):e0177134. doi: 10.1371/journal.pone.0177134 [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Pearson RD, Amato R, Auburn S, Miotto O, Almagro-Garcia J, Amaratunga C, et al. Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat Genet. 2016;48(8):959–64. doi: 10.1038/ng.3599 [DOI] [PMC free article] [PubMed] [Google Scholar]
26.Rice BL, Acosta MM, Pacheco MA, Carlton JM, Barnwell JW, Escalante AA. The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites. Mol Phylogenet Evol. 2014;78:172–84. doi: 10.1016/j.ympev.2014.05.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
27.Hester J, Chan ER, Menard D, Mercereau-Puijalon O, Barnwell J, Zimmerman PA, et al. De novo assembly of a field isolate genome reveals novel Plasmodium vivax erythrocyte invasion genes. PLoS Negl Trop Dis. 2013;7(12):e2569. doi: 10.1371/journal.pntd.0002569 [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Carias LL, Dechavanne S, Nicolete VC, Sreng S, Suon S, Amaratunga C, et al. Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein. J Immunol. 2019;202(9):2648–60. doi: 10.4049/jimmunol.1801631 [DOI] [PMC free article] [PubMed] [Google Scholar]
29.He WQ, Shakri AR, Bhardwaj R, Franca CT, Stanisic DI, Healer J, et al. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria. PLoS Negl Trop Dis. 2019;13(2):e0006987. doi: 10.1371/journal.pntd.0006987 [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Gruszczyk J, Lim NT, Arnott A, He WQ, Nguitragool W, Roobsoong W, et al. Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement. Proc Natl Acad Sci U S A. 2016;113(2):E191–200. doi: 10.1073/pnas.1516512113 [DOI] [PMC free article] [PubMed] [Google Scholar]
31.Han JH, Lee SK, Wang B, Muh F, Nyunt MH, Na S, et al. Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain. Sci Rep. 2016;6:26993. doi: 10.1038/srep26993 [DOI] [PMC free article] [PubMed] [Google Scholar]
32.Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, et al. Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat Genet. 2012;44(9):1051–5. doi: 10.1038/ng.2375 [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Malleret B, El Sahili A, Tay MZ, Carissimo G, Ong ASM, Novera W, et al. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells. Nat Microbiol. 2021;6(8):991–9. doi: 10.1038/s41564-021-00939-3 [DOI] [PubMed] [Google Scholar]
34.Gruszczyk J, Kanjee U, Chan LJ, Menant S, Malleret B, Lim NTY, et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science. 2018;359(6371):48–55. doi: 10.1126/science.aan1078 [DOI] [PMC free article] [PubMed] [Google Scholar]
35.Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, et al. Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. Vaccine. 2002;20(9–10):1331–9. doi: 10.1016/s0264-410x(01)00472-8 [DOI] [PubMed] [Google Scholar]
36.Tyagi RK, Sharma YD. Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients’ Antibodies. PLoS One. 2012;7(12):e50754. doi: 10.1371/journal.pone.0050754 [DOI] [PMC free article] [PubMed] [Google Scholar]
37.Alam MS, Choudhary V, Zeeshan M, Tyagi RK, Rathore S, Sharma YD. Interaction of Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 with Band 3 on Human Erythrocyte Surface Facilitates Parasite Growth. J Biol Chem. 2015;290(33):20257–72. doi: 10.1074/jbc.M115.644906 [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Zhu L, Mok S, Imwong M, Jaidee A, Russell B, Nosten F, et al. New insights into the Plasmodium vivax transcriptome using RNA-Seq. Sci Rep. 2016;6:20498. doi: 10.1038/srep20498 [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Siegel SV, Chappell L, Hostetler JB, Amaratunga C, Suon S, Bohme U, et al. Analysis of Plasmodium vivax schizont transcriptomes from field isolates reveals heterogeneity of expression of genes involved in host-parasite interactions. Sci Rep. 2020;10(1):16667. doi: 10.1038/s41598-020-73562-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
40.Rangel GW, Clark MA, Kanjee U, Goldberg JM, MacInnis B, Jose Menezes M, et al. Plasmodium vivax transcriptional profiling of low input cryopreserved isolates through the intraerythrocytic development cycle. PLoS Negl Trop Dis. 2020;14(3):e0008104. doi: 10.1371/journal.pntd.0008104 [DOI] [PMC free article] [PubMed] [Google Scholar]
41.Bowyer PW, Stewart LB, Aspeling-Jones H, Mensah-Brown HE, Ahouidi AD, Amambua-Ngwa A, et al. Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity. Infect Immun. 2015;83(6):2575–82. doi: 10.1128/IAI.03009-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
42.Cortes A, Crowley VM, Vaquero A, Voss TS. A view on the role of epigenetics in the biology of malaria parasites. PLoS Pathog. 2012;8(12):e1002943. doi: 10.1371/journal.ppat.1002943 [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Ford A, Kepple D, Williams J, Kolesar G, Ford CT, Abebe A, et al. Gene Polymorphisms Among Plasmodium vivax Geographical Isolates and the Potential as New Biomarkers for Gametocyte Detection. Front Cell Infect Microbiol. 2021;11:789417. doi: 10.3389/fcimb.2021.789417 [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–15. doi: 10.1038/s41587-019-0201-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
45.Soneson C. hisat2: R Wrapper for HISAT2 Aligner. R package version 1120,. 2022. [Google Scholar]
46.Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078–9. doi: 10.1093/bioinformatics/btp352 [DOI] [PMC free article] [PubMed] [Google Scholar]
47.Morgan M PH, Obenchain V, Hayden N. Rsamtools: Binary alignment (BAM), FASTA, variant call (BCF), and tabix file import. R package version 2120. 2022. [Google Scholar]
48.Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47(8):e47. doi: 10.1093/nar/gkz114 [DOI] [PMC free article] [PubMed] [Google Scholar]
49.Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–82. doi: 10.1038/s41587-019-0114-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
50.Tebben K, Dia A, Serre D. Determination of the Stage Composition of Plasmodium Infections from Bulk Gene Expression Data. mSystems. 2022:e0025822. doi: 10.1128/msystems.00258-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
51.Kepple D, Pestana K, Tomida J, Abebe A, Golassa L, Lo E. Alternative Invasion Mechanisms and Host Immune Response to Plasmodium vivax Malaria: Trends and Future Directions. Microorganisms. 2020;9(1). doi: 10.3390/microorganisms9010015 [DOI] [PMC free article] [PubMed] [Google Scholar]
52.Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40. doi: 10.1093/bioinformatics/btp616 [DOI] [PMC free article] [PubMed] [Google Scholar]
53.Kim A, Popovici J, Menard D, Serre D. Plasmodium vivax transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes. Nat Commun. 2019;10(1):371. doi: 10.1038/s41467-019-08312-z [DOI] [PMC free article] [PubMed] [Google Scholar]
54.Mancio-Silva L, Gural N, Real E, Wadsworth MH, Butty VL 2nd, March S, et al. A single-cell liver atlas of Plasmodium vivax infection. Cell Host Microbe. 2022;30(7):1048–60 e5. doi: 10.1016/j.chom.2022.03.034 [DOI] [PubMed] [Google Scholar]
55.Hoffman GE, Roussos P. Dream: powerful differential expression analysis for repeated measures designs. Bioinformatics. 2021;37(2):192–201. doi: 10.1093/bioinformatics/btaa687 [DOI] [PMC free article] [PubMed] [Google Scholar]
56.Hoffman GE, Schadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics. 2016;17(1):483. doi: 10.1186/s12859-016-1323-z [DOI] [PMC free article] [PubMed] [Google Scholar]
57.Gupta S, Singh S, Popovici J, Roesch C, Shakri AR, Guillotte-Blisnick M, et al. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax. Sci Rep. 2018;8(1):10511. doi: 10.1038/s41598-018-28757-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Hietanen J, Chim-Ong A, Chiramanewong T, Gruszczyk J, Roobsoong W, Tham WH, et al. Gene Models, Expression Repertoire, and Immune Response of Plasmodium vivax Reticulocyte Binding Proteins. Infect Immun. 2015;84(3):677–85. doi: 10.1128/IAI.01117-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
59.Kepple D, Hubbard A, Ali MM, Abargero BR, Lopez K, Pestana K, et al. Plasmodium vivax From Duffy-Negative and Duffy-Positive Individuals Share Similar Gene Pools in East Africa. J Infect Dis. 2021;224(8):1422–31. doi: 10.1093/infdis/jiab063 [DOI] [PMC free article] [PubMed] [Google Scholar]
60.Cui L, Miao J. Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum. Eukaryot Cell. 2010;9(8):1138–49. doi: 10.1128/EC.00036-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
61.Gupta AP, Chin WH, Zhu L, Mok S, Luah YH, Lim EH, et al. Dynamic epigenetic regulation of gene expression during the life cycle of malaria parasite Plasmodium falciparum. PLoS Pathog. 2013;9(2):e1003170. doi: 10.1371/journal.ppat.1003170 [DOI] [PMC free article] [PubMed] [Google Scholar]
62.Ragotte RJ, Higgins MK, Draper SJ. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target. Trends Parasitol. 2020;36(6):545–59. doi: 10.1016/j.pt.2020.04.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
63.Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature. 2011;480(7378):534–7. doi: 10.1038/nature10606 [DOI] [PMC free article] [PubMed] [Google Scholar]
64.Volz JC, Yap A, Sisquella X, Thompson JK, Lim NT, Whitehead LW, et al. Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes. Cell Host Microbe. 2016;20(1):60–71. doi: 10.1016/j.chom.2016.06.004 [DOI] [PubMed] [Google Scholar]
65.Partey FD, Castberg FC, Sarbah EW, Silk SE, Awandare GA, Draper SJ, et al. Correction: Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria. PLoS One. 2018;13(9):e0204452. doi: 10.1371/journal.pone.0204452 [DOI] [PMC free article] [PubMed] [Google Scholar]
66.Sierra AY, Barrero CA, Rodriguez R, Silva Y, Moncada C, Vanegas M, et al. Splenectomised and spleen intact Aotus monkeys’ immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides. Vaccine. 2003;21(27–30):4133–44. doi: 10.1016/s0264-410x(03)00455-9 [DOI] [PubMed] [Google Scholar]
67.Rougeron V, Elguero E, Arnathau C, Acuna Hidalgo B, Durand P, Houze S, et al. Human Plasmodium vivax diversity, population structure and evolutionary origin. PLoS Negl Trop Dis. 2020;14(3):e0008072. doi: 10.1371/journal.pntd.0008072 [DOI] [PMC free article] [PubMed] [Google Scholar]
68.Hupalo DN, Luo Z, Melnikov A, Sutton PL, Rogov P, Escalante A, et al. Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax. Nat Genet. 2016;48(8):953–8. doi: 10.1038/ng.3588 [DOI] [PMC free article] [PubMed] [Google Scholar]
69.Benavente ED, Manko E, Phelan J, Campos M, Nolder D, Fernandez D, et al. Distinctive genetic structure and selection patterns in Plasmodium vivax from South Asia and East Africa. Nat Commun. 2021;12(1):3160. doi: 10.1038/s41467-021-23422-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
70.Kumar M, Skillman K, Duraisingh MT. Linking nutrient sensing and gene expression in Plasmodium falciparum blood-stage parasites. Mol Microbiol. 2021;115(5):891–900. doi: 10.1111/mmi.14652 [DOI] [PMC free article] [PubMed] [Google Scholar]
71.Alexandre MA, Benzecry SG, Siqueira AM, Vitor-Silva S, Melo GC, Monteiro WM, et al. The association between nutritional status and malaria in children from a rural community in the Amazonian region: a longitudinal study. PLoS Negl Trop Dis. 2015;9(4):e0003743. doi: 10.1371/journal.pntd.0003743 [DOI] [PMC free article] [PubMed] [Google Scholar]
72.McCurley AT, Callard GV. Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol Biol. 2008;9:102. doi: 10.1186/1471-2199-9-102 [DOI] [PMC free article] [PubMed] [Google Scholar]
73.Yam XY, Brugat T, Siau A, Lawton J, Wong DS, Farah A, et al. Characterization of the Plasmodium Interspersed Repeats (PIR) proteins of Plasmodium chabaudi indicates functional diversity. Sci Rep. 2016;6:23449. doi: 10.1038/srep23449 [DOI] [PMC free article] [PubMed] [Google Scholar]
74.Cunningham D, Lawton J, Jarra W, Preiser P, Langhorne J. The pir multigene family of Plasmodium: antigenic variation and beyond. Mol Biochem Parasitol. 2010;170(2):65–73. doi: 10.1016/j.molbiopara.2009.12.010 [DOI] [PubMed] [Google Scholar]
75.Little TS, Cunningham DA, Vandomme A, Lopez CT, Amis S, Alder C, et al. Analysis of pir gene expression across the Plasmodium life cycle. Malar J. 2021;20(1):445. doi: 10.1186/s12936-021-03979-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
76.del Portillo HA, Fernandez-Becerra C, Bowman S, Oliver K, Preuss M, Sanchez CP, et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature. 2001;410(6830):839–42. doi: 10.1038/35071118 [DOI] [PubMed] [Google Scholar]
77.Bernabeu M, Lopez FJ, Ferrer M, Martin-Jaular L, Razaname A, Corradin G, et al. Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor. Cell Microbiol. 2012;14(3):386–400. doi: 10.1111/j.1462-5822.2011.01726.x [DOI] [PubMed] [Google Scholar]
78.Requena P, Rui E, Padilla N, Martinez-Espinosa FE, Castellanos ME, Botto-Menezes C, et al. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women. PLoS Negl Trop Dis. 2016;10(10):e0005009. doi: 10.1371/journal.pntd.0005009 [DOI] [PMC free article] [PubMed] [Google Scholar]
79.Cook J, Speybroeck N, Sochanta T, Somony H, Sokny M, Claes F, et al. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J. 2012;11:86. doi: 10.1186/1475-2875-11-86 [DOI] [PMC free article] [PubMed] [Google Scholar]
80.Hollin T, Le Roch KG. From Genes to Transcripts, a Tightly Regulated Journey in Plasmodium. Front Cell Infect Microbiol. 2020;10:618454. doi: 10.3389/fcimb.2020.618454 [DOI] [PMC free article] [PubMed] [Google Scholar]
81.Hoo R, Zhu L, Amaladoss A, Mok S, Natalang O, Lapp SA, et al. Integrated analysis of the Plasmodium species transcriptome. EBioMedicine. 2016;7:255–66. doi: 10.1016/j.ebiom.2016.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
82.Sa JM, Cannon MV, Caleon RL, Wellems TE, Serre D. Single-cell transcription analysis of Plasmodium vivax blood-stage parasites identifies stage- and species-specific profiles of expression. PLoS Biol. 2020;18(5):e3000711. doi: 10.1371/journal.pbio.3000711 [DOI] [PMC free article] [PubMed] [Google Scholar]
83.Liu F, Yang F, Wang Y, Hong M, Zheng W, Min H, et al. A conserved malaria parasite antigen Pb22 plays a critical role in male gametogenesis in Plasmodium berghei. Cell Microbiol. 2021;23(3):e13294. doi: 10.1111/cmi.13294 [DOI] [PMC free article] [PubMed] [Google Scholar]
84.Yuda M, Kaneko I, Murata Y, Iwanaga S, Nishi T. Mechanisms of triggering malaria gametocytogenesis by AP2-G. Parasitol Int. 2021;84:102403. doi: 10.1016/j.parint.2021.102403 [DOI] [PubMed] [Google Scholar]
85.Abdelraheem MH, Bansal D, Idris MA, Mukhtar MM, Hamid MMA, Imam ZS, et al. Genetic diversity and transmissibility of imported Plasmodium vivax in Qatar and three countries of origin. Sci Rep. 2018;8(1):8870. doi: 10.1038/s41598-018-27229-z [DOI] [PMC free article] [PubMed] [Google Scholar]
86.Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12(12):833–40. doi: 10.1038/nrmicro3364 [DOI] [PubMed] [Google Scholar]
87.Hofmann NE, Gruenberg M, Nate E, Ura A, Rodriguez-Rodriguez D, Salib M, et al. Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study. Lancet Infect Dis. 2018;18(10):1108–16. doi: 10.1016/S1473-3099(18)30411-0 [DOI] [PubMed] [Google Scholar]
88.Kosasih A, Koepfli C, Dahlan MS, Hawley WA, Baird JK, Mueller I, et al. Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study. Malar J. 2021;20(1):177. doi: 10.1186/s12936-021-03709-y [DOI] [PMC free article] [PubMed] [Google Scholar]

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011926.r001

Decision Letter 0

Ananias A Escalante, Walderez O Dutra

6 Dec 2023

Dear Dr. Kepple,

Thank you very much for submitting your manuscript "Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Ananias A. Escalante, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Walderez Dutra

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: Objectives and methods are properly described. Statistical analysis seems appropriate. No ehtical concerns were identified.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Overall, the manuscript is well written and results are prearly presented and discussed.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Comparing Plasmodium vivax transcriptomes obtained with different study protocols is necessarily challenging. This authors might perhaps discuss the potential limitations of the comparative approach in greater detail.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: None.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: Kepple and colleagues have generated 10 new transcriptomes of Plasmodium vivax isolates from Ethiopia and compare their results with previously published data from Cambodia (4 transcriptomes) and Brazil (2 transcriptomes).

In two of the studies (Ethiopia and Brazil), cryopreserved, patient-derived isolates were thawed and maintained in short-term culture ex-vivo for approximately 40-44 hours, under slightly different conditions, for schizont maturation; in one study (Cambodia), fresh parasites were used for ex-vivo maturation. The key question is whether differences in transcriptomic profiles among parasites were mostly due to the geographic origin of parasites (Horn of Africa vs. Southeast Asia vs. Amazon Basin in South America) or to differences in sample preparation protocols prior to transcriptomic analysis. This question deserves deeper discussion throughout the manuscript.

Interestingly, CIBERSORTx deconvolution analysis shows the presence of some ring-stage transcripts in Brazilian isolates (Figure 1), which is unexpected after the ex-vivo maturation process. However, the difference in the proportion of late trophozoites and schizonts among samples of different geographic origin did not reach statistical significance.

Why are transcriptomes of Cambodian and African parasites more similar to each other than they are to those from South American samples is not entirely clear. Population genomic analyses (e.g., doi: 10.1038/ng.3588) typically show greater similarity between African and American lineages of P. vivax , compared with Southeast Asian lineages. Again, can this be due to differences in study protocols used for samples processing and transcriptomic analyses rather than geographic differences in transcription patterns?

Two minor comments:

1. Because the genes coding for the PIR family in P. vivax had originally been described as the vir multigene family in P. vivax, the nomenclature may be a bit confusing.

2. The authors coreectly state that "malnourishment has a protective effect to P. vivax infections in people from the western Brazilian Amazon (70)". Yes, there is a single cross-sectional report of such an association in children, with suboptimal controlling for confounders, which cannot be taken as evidence for a causal association between malnutrition and protection from malaria. I suggest these data are not overinterpreted in this context (differences between the transcriptomes of two P. vivax lineages from adults in Brazil and those from other geographic regions) as population-based nutritional status data from the study sites are not considered here.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. 2024 Jan 29;18(1):e0011926. doi: 10.1371/journal.pntd.0011926.r002

Author response to Decision Letter 0

26 Dec 2023

Attachment

Submitted filename: Responses to Reviewers.pdf

pntd.0011926.s003.pdf^{(16.2KB, pdf)}

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011926.r003

Decision Letter 1

Walderez O Dutra

19 Jan 2024

Dear Dr. Kepple,

We are pleased to inform you that your manuscript 'Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Walderez O. Dutra, PhD.

Section Editor

PLOS Neglected Tropical Diseases

Walderez Dutra

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

**********

Editorial and Data Presentation Modifications?

Reviewer #1: (No Response)

**********

Summary and General Comments

Reviewer #1: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Marcelo U. Ferreira

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011926.r004

Acceptance letter

Walderez O Dutra

25 Jan 2024

Dear Dr. Kepple,

We are delighted to inform you that your manuscript, "Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Name and gene ID of 43 candidate invasion genes.

(XLSX)

pntd.0011926.s001.xlsx^{(9.4KB, xlsx)}

S2 Table

Kenward-Roger DE analyses comparing the differentially expressed genes between (a) Ethiopian and Cambodian, (b) Ethiopian and Brazilian, and (c) Cambodian and Brazilian P. vivax.

(XLSX)

pntd.0011926.s002.xlsx^{(417.1KB, xlsx)}

Attachment

Submitted filename: Responses to Reviewers.pdf

pntd.0011926.s003.pdf^{(16.2KB, pdf)}

Data Availability Statement

[pntd.0011926.ref001] 1.Chitnis CE, Miller LH. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med. 1994;180(2):497–506. doi: 10.1084/jem.180.2.497 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref002] 2.Fang XD, Kaslow DC, Adams JH, Miller LH. Cloning of the Plasmodium vivax Duffy receptor. Mol Biochem Parasitol. 1991;44(1):125–32. doi: 10.1016/0166-6851(91)90228-x [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref003] 3.Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, et al. The global distribution of the Duffy blood group. Nat Commun. 2011;2:266. doi: 10.1038/ncomms1265 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref004] 4.Gunalan K, Lo E, Hostetler JB, Yewhalaw D, Mu J, Neafsey DE, et al. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proc Natl Acad Sci U S A. 2016;113(22):6271–6. doi: 10.1073/pnas.1606113113 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref005] 5.Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A. 2010;107(13):5967–71. doi: 10.1073/pnas.0912496107 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref006] 6.Menard D, Chan ER, Benedet C, Ratsimbasoa A, Kim S, Chim P, et al. Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains. PLoS Negl Trop Dis. 2013;7(11):e2489. doi: 10.1371/journal.pntd.0002489 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref007] 7.Escalante AA, Cepeda AS, Pacheco MA. Why Plasmodium vivax and Plasmodium falciparum are so different? A tale of two clades and their species diversities. Malar J. 2022;21(1):139. doi: 10.1186/s12936-022-04130-9 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref008] 8.Luo Z, Sullivan SA, Carlton JM. The biology of Plasmodium vivax explored through genomics. Ann N Y Acad Sci. 2015;1342:53–61. doi: 10.1111/nyas.12708 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref009] 9.Rougeron V, Boundenga L, Arnathau C, Durand P, Prugnolle F. The origin of Plasmodium vivax: science or story telling? FEMS Microbiol Rev. 2022;46(4). [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref010] 10.Daron J, Boissiere A, Boundenga L, Ngoubangoye B, Houze S, Arnathau C, et al. Population genomic evidence of Plasmodium vivax Southeast Asian origin. Sci Adv. 2021;7(18). doi: 10.1126/sciadv.abc3713 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref011] 11.Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008;455(7214):757–63. doi: 10.1038/nature07327 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref012] 12.Auburn S, Bohme U, Steinbiss S, Trimarsanto H, Hostetler J, Sanders M, et al. A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes. Wellcome Open Res. 2016;1:4. doi: 10.12688/wellcomeopenres.9876.1 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref013] 13.Ford A, Kepple D, Abagero BR, Connors J, Pearson R, Auburn S, et al. Whole genome sequencing of Plasmodium vivax isolates reveals frequent sequence and structural polymorphisms in erythrocyte binding genes. PLoS Negl Trop Dis. 2020;14(10):e0008234. doi: 10.1371/journal.pntd.0008234 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref014] 14.White MT, Shirreff G, Karl S, Ghani AC, Mueller I. Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria. Proc Biol Sci. 2016;283(1827):20160048. doi: 10.1098/rspb.2016.0048 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref015] 15.Auburn S, Benavente ED, Miotto O, Pearson RD, Amato R, Grigg MJ, et al. Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics. Nat Commun. 2018;9(1):2585. doi: 10.1038/s41467-018-04965-4 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref016] 16.Roesch C, Popovici J, Bin S, Run V, Kim S, Ramboarina S, et al. Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion. PLoS Negl Trop Dis. 2018;12(10):e0006555. doi: 10.1371/journal.pntd.0006555 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref017] 17.Arevalo-Pinzon G, Bermudez M, Curtidor H, Patarroyo MA. The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes. Malar J. 2015;14:106. doi: 10.1186/s12936-015-0619-1 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref018] 18.Baquero LA, Moreno-Perez DA, Garzon-Ospina D, Forero-Rodriguez J, Ortiz-Suarez HD, Patarroyo MA. PvGAMA reticulocyte binding activity: predicting conserved functional regions by natural selection analysis. Parasit Vectors. 2017;10(1):251. doi: 10.1186/s13071-017-2183-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref019] 19.Gunalan K, Sa JM, Moraes Barros RR, Anzick SL, Caleon RL, Mershon JP, et al. Transcriptome profiling of Plasmodium vivax in Saimiri monkeys identifies potential ligands for invasion. Proc Natl Acad Sci U S A. 2019;116(14):7053–61. doi: 10.1073/pnas.1818485116 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref020] 20.Tyagi K, Hossain ME, Thakur V, Aggarwal P, Malhotra P, Mohmmed A, et al. Plasmodium vivax Tryptophan Rich Antigen PvTRAg36.6 Interacts with PvETRAMP and PvTRAg56.6 Interacts with PvMSP7 during Erythrocytic Stages of the Parasite. PLoS One. 2016;11(3):e0151065. doi: 10.1371/journal.pone.0151065 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref021] 21.Wang B, Lu F, Cheng Y, Chen JH, Jeon HY, Ha KS, et al. Correction for Wang et al., "Immunoprofiling of the Tryptophan-Rich Antigen Family in Plasmodium vivax". Infect Immun. 2018;86(4). [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref022] 22.Chen SB, Wang Y, Kassegne K, Xu B, Shen HM, Chen JH. Whole-genome sequencing of a Plasmodium vivax clinical isolate exhibits geographical characteristics and high genetic variation in China-Myanmar border area. BMC Genomics. 2017;18(1):131. doi: 10.1186/s12864-017-3523-y [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref023] 23.Cornejo OE, Fisher D, Escalante AA. Genome-wide patterns of genetic polymorphism and signatures of selection in Plasmodium vivax. Genome Biol Evol. 2014;7(1):106–19. doi: 10.1093/gbe/evu267 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref024] 24.Diez Benavente E, Ward Z, Chan W, Mohareb FR, Sutherland CJ, Roper C, et al. Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure. PLoS One. 2017;12(5):e0177134. doi: 10.1371/journal.pone.0177134 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref025] 25.Pearson RD, Amato R, Auburn S, Miotto O, Almagro-Garcia J, Amaratunga C, et al. Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat Genet. 2016;48(8):959–64. doi: 10.1038/ng.3599 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref026] 26.Rice BL, Acosta MM, Pacheco MA, Carlton JM, Barnwell JW, Escalante AA. The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites. Mol Phylogenet Evol. 2014;78:172–84. doi: 10.1016/j.ympev.2014.05.013 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref027] 27.Hester J, Chan ER, Menard D, Mercereau-Puijalon O, Barnwell J, Zimmerman PA, et al. De novo assembly of a field isolate genome reveals novel Plasmodium vivax erythrocyte invasion genes. PLoS Negl Trop Dis. 2013;7(12):e2569. doi: 10.1371/journal.pntd.0002569 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref028] 28.Carias LL, Dechavanne S, Nicolete VC, Sreng S, Suon S, Amaratunga C, et al. Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein. J Immunol. 2019;202(9):2648–60. doi: 10.4049/jimmunol.1801631 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref029] 29.He WQ, Shakri AR, Bhardwaj R, Franca CT, Stanisic DI, Healer J, et al. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria. PLoS Negl Trop Dis. 2019;13(2):e0006987. doi: 10.1371/journal.pntd.0006987 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref030] 30.Gruszczyk J, Lim NT, Arnott A, He WQ, Nguitragool W, Roobsoong W, et al. Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement. Proc Natl Acad Sci U S A. 2016;113(2):E191–200. doi: 10.1073/pnas.1516512113 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref031] 31.Han JH, Lee SK, Wang B, Muh F, Nyunt MH, Na S, et al. Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain. Sci Rep. 2016;6:26993. doi: 10.1038/srep26993 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref032] 32.Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, et al. Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat Genet. 2012;44(9):1051–5. doi: 10.1038/ng.2375 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref033] 33.Malleret B, El Sahili A, Tay MZ, Carissimo G, Ong ASM, Novera W, et al. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells. Nat Microbiol. 2021;6(8):991–9. doi: 10.1038/s41564-021-00939-3 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref034] 34.Gruszczyk J, Kanjee U, Chan LJ, Menant S, Malleret B, Lim NTY, et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science. 2018;359(6371):48–55. doi: 10.1126/science.aan1078 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref035] 35.Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, et al. Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. Vaccine. 2002;20(9–10):1331–9. doi: 10.1016/s0264-410x(01)00472-8 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref036] 36.Tyagi RK, Sharma YD. Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients’ Antibodies. PLoS One. 2012;7(12):e50754. doi: 10.1371/journal.pone.0050754 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref037] 37.Alam MS, Choudhary V, Zeeshan M, Tyagi RK, Rathore S, Sharma YD. Interaction of Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 with Band 3 on Human Erythrocyte Surface Facilitates Parasite Growth. J Biol Chem. 2015;290(33):20257–72. doi: 10.1074/jbc.M115.644906 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref038] 38.Zhu L, Mok S, Imwong M, Jaidee A, Russell B, Nosten F, et al. New insights into the Plasmodium vivax transcriptome using RNA-Seq. Sci Rep. 2016;6:20498. doi: 10.1038/srep20498 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref039] 39.Siegel SV, Chappell L, Hostetler JB, Amaratunga C, Suon S, Bohme U, et al. Analysis of Plasmodium vivax schizont transcriptomes from field isolates reveals heterogeneity of expression of genes involved in host-parasite interactions. Sci Rep. 2020;10(1):16667. doi: 10.1038/s41598-020-73562-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref040] 40.Rangel GW, Clark MA, Kanjee U, Goldberg JM, MacInnis B, Jose Menezes M, et al. Plasmodium vivax transcriptional profiling of low input cryopreserved isolates through the intraerythrocytic development cycle. PLoS Negl Trop Dis. 2020;14(3):e0008104. doi: 10.1371/journal.pntd.0008104 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref041] 41.Bowyer PW, Stewart LB, Aspeling-Jones H, Mensah-Brown HE, Ahouidi AD, Amambua-Ngwa A, et al. Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity. Infect Immun. 2015;83(6):2575–82. doi: 10.1128/IAI.03009-14 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref042] 42.Cortes A, Crowley VM, Vaquero A, Voss TS. A view on the role of epigenetics in the biology of malaria parasites. PLoS Pathog. 2012;8(12):e1002943. doi: 10.1371/journal.ppat.1002943 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref043] 43.Ford A, Kepple D, Williams J, Kolesar G, Ford CT, Abebe A, et al. Gene Polymorphisms Among Plasmodium vivax Geographical Isolates and the Potential as New Biomarkers for Gametocyte Detection. Front Cell Infect Microbiol. 2021;11:789417. doi: 10.3389/fcimb.2021.789417 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref044] 44.Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–15. doi: 10.1038/s41587-019-0201-4 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref045] 45.Soneson C. hisat2: R Wrapper for HISAT2 Aligner. R package version 1120,. 2022. [Google Scholar]

[pntd.0011926.ref046] 46.Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078–9. doi: 10.1093/bioinformatics/btp352 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref047] 47.Morgan M PH, Obenchain V, Hayden N. Rsamtools: Binary alignment (BAM), FASTA, variant call (BCF), and tabix file import. R package version 2120. 2022. [Google Scholar]

[pntd.0011926.ref048] 48.Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47(8):e47. doi: 10.1093/nar/gkz114 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref049] 49.Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–82. doi: 10.1038/s41587-019-0114-2 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref050] 50.Tebben K, Dia A, Serre D. Determination of the Stage Composition of Plasmodium Infections from Bulk Gene Expression Data. mSystems. 2022:e0025822. doi: 10.1128/msystems.00258-22 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref051] 51.Kepple D, Pestana K, Tomida J, Abebe A, Golassa L, Lo E. Alternative Invasion Mechanisms and Host Immune Response to Plasmodium vivax Malaria: Trends and Future Directions. Microorganisms. 2020;9(1). doi: 10.3390/microorganisms9010015 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref052] 52.Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40. doi: 10.1093/bioinformatics/btp616 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref053] 53.Kim A, Popovici J, Menard D, Serre D. Plasmodium vivax transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes. Nat Commun. 2019;10(1):371. doi: 10.1038/s41467-019-08312-z [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref054] 54.Mancio-Silva L, Gural N, Real E, Wadsworth MH, Butty VL 2nd, March S, et al. A single-cell liver atlas of Plasmodium vivax infection. Cell Host Microbe. 2022;30(7):1048–60 e5. doi: 10.1016/j.chom.2022.03.034 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref055] 55.Hoffman GE, Roussos P. Dream: powerful differential expression analysis for repeated measures designs. Bioinformatics. 2021;37(2):192–201. doi: 10.1093/bioinformatics/btaa687 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref056] 56.Hoffman GE, Schadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics. 2016;17(1):483. doi: 10.1186/s12859-016-1323-z [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref057] 57.Gupta S, Singh S, Popovici J, Roesch C, Shakri AR, Guillotte-Blisnick M, et al. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax. Sci Rep. 2018;8(1):10511. doi: 10.1038/s41598-018-28757-4 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref058] 58.Hietanen J, Chim-Ong A, Chiramanewong T, Gruszczyk J, Roobsoong W, Tham WH, et al. Gene Models, Expression Repertoire, and Immune Response of Plasmodium vivax Reticulocyte Binding Proteins. Infect Immun. 2015;84(3):677–85. doi: 10.1128/IAI.01117-15 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref059] 59.Kepple D, Hubbard A, Ali MM, Abargero BR, Lopez K, Pestana K, et al. Plasmodium vivax From Duffy-Negative and Duffy-Positive Individuals Share Similar Gene Pools in East Africa. J Infect Dis. 2021;224(8):1422–31. doi: 10.1093/infdis/jiab063 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref060] 60.Cui L, Miao J. Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum. Eukaryot Cell. 2010;9(8):1138–49. doi: 10.1128/EC.00036-10 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref061] 61.Gupta AP, Chin WH, Zhu L, Mok S, Luah YH, Lim EH, et al. Dynamic epigenetic regulation of gene expression during the life cycle of malaria parasite Plasmodium falciparum. PLoS Pathog. 2013;9(2):e1003170. doi: 10.1371/journal.ppat.1003170 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref062] 62.Ragotte RJ, Higgins MK, Draper SJ. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target. Trends Parasitol. 2020;36(6):545–59. doi: 10.1016/j.pt.2020.04.003 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref063] 63.Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature. 2011;480(7378):534–7. doi: 10.1038/nature10606 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref064] 64.Volz JC, Yap A, Sisquella X, Thompson JK, Lim NT, Whitehead LW, et al. Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes. Cell Host Microbe. 2016;20(1):60–71. doi: 10.1016/j.chom.2016.06.004 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref065] 65.Partey FD, Castberg FC, Sarbah EW, Silk SE, Awandare GA, Draper SJ, et al. Correction: Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria. PLoS One. 2018;13(9):e0204452. doi: 10.1371/journal.pone.0204452 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref066] 66.Sierra AY, Barrero CA, Rodriguez R, Silva Y, Moncada C, Vanegas M, et al. Splenectomised and spleen intact Aotus monkeys’ immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides. Vaccine. 2003;21(27–30):4133–44. doi: 10.1016/s0264-410x(03)00455-9 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref067] 67.Rougeron V, Elguero E, Arnathau C, Acuna Hidalgo B, Durand P, Houze S, et al. Human Plasmodium vivax diversity, population structure and evolutionary origin. PLoS Negl Trop Dis. 2020;14(3):e0008072. doi: 10.1371/journal.pntd.0008072 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref068] 68.Hupalo DN, Luo Z, Melnikov A, Sutton PL, Rogov P, Escalante A, et al. Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax. Nat Genet. 2016;48(8):953–8. doi: 10.1038/ng.3588 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref069] 69.Benavente ED, Manko E, Phelan J, Campos M, Nolder D, Fernandez D, et al. Distinctive genetic structure and selection patterns in Plasmodium vivax from South Asia and East Africa. Nat Commun. 2021;12(1):3160. doi: 10.1038/s41467-021-23422-3 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref070] 70.Kumar M, Skillman K, Duraisingh MT. Linking nutrient sensing and gene expression in Plasmodium falciparum blood-stage parasites. Mol Microbiol. 2021;115(5):891–900. doi: 10.1111/mmi.14652 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref071] 71.Alexandre MA, Benzecry SG, Siqueira AM, Vitor-Silva S, Melo GC, Monteiro WM, et al. The association between nutritional status and malaria in children from a rural community in the Amazonian region: a longitudinal study. PLoS Negl Trop Dis. 2015;9(4):e0003743. doi: 10.1371/journal.pntd.0003743 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref072] 72.McCurley AT, Callard GV. Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol Biol. 2008;9:102. doi: 10.1186/1471-2199-9-102 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref073] 73.Yam XY, Brugat T, Siau A, Lawton J, Wong DS, Farah A, et al. Characterization of the Plasmodium Interspersed Repeats (PIR) proteins of Plasmodium chabaudi indicates functional diversity. Sci Rep. 2016;6:23449. doi: 10.1038/srep23449 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref074] 74.Cunningham D, Lawton J, Jarra W, Preiser P, Langhorne J. The pir multigene family of Plasmodium: antigenic variation and beyond. Mol Biochem Parasitol. 2010;170(2):65–73. doi: 10.1016/j.molbiopara.2009.12.010 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref075] 75.Little TS, Cunningham DA, Vandomme A, Lopez CT, Amis S, Alder C, et al. Analysis of pir gene expression across the Plasmodium life cycle. Malar J. 2021;20(1):445. doi: 10.1186/s12936-021-03979-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref076] 76.del Portillo HA, Fernandez-Becerra C, Bowman S, Oliver K, Preuss M, Sanchez CP, et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature. 2001;410(6830):839–42. doi: 10.1038/35071118 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref077] 77.Bernabeu M, Lopez FJ, Ferrer M, Martin-Jaular L, Razaname A, Corradin G, et al. Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor. Cell Microbiol. 2012;14(3):386–400. doi: 10.1111/j.1462-5822.2011.01726.x [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref078] 78.Requena P, Rui E, Padilla N, Martinez-Espinosa FE, Castellanos ME, Botto-Menezes C, et al. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women. PLoS Negl Trop Dis. 2016;10(10):e0005009. doi: 10.1371/journal.pntd.0005009 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref079] 79.Cook J, Speybroeck N, Sochanta T, Somony H, Sokny M, Claes F, et al. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J. 2012;11:86. doi: 10.1186/1475-2875-11-86 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref080] 80.Hollin T, Le Roch KG. From Genes to Transcripts, a Tightly Regulated Journey in Plasmodium. Front Cell Infect Microbiol. 2020;10:618454. doi: 10.3389/fcimb.2020.618454 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref081] 81.Hoo R, Zhu L, Amaladoss A, Mok S, Natalang O, Lapp SA, et al. Integrated analysis of the Plasmodium species transcriptome. EBioMedicine. 2016;7:255–66. doi: 10.1016/j.ebiom.2016.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref082] 82.Sa JM, Cannon MV, Caleon RL, Wellems TE, Serre D. Single-cell transcription analysis of Plasmodium vivax blood-stage parasites identifies stage- and species-specific profiles of expression. PLoS Biol. 2020;18(5):e3000711. doi: 10.1371/journal.pbio.3000711 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref083] 83.Liu F, Yang F, Wang Y, Hong M, Zheng W, Min H, et al. A conserved malaria parasite antigen Pb22 plays a critical role in male gametogenesis in Plasmodium berghei. Cell Microbiol. 2021;23(3):e13294. doi: 10.1111/cmi.13294 [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref084] 84.Yuda M, Kaneko I, Murata Y, Iwanaga S, Nishi T. Mechanisms of triggering malaria gametocytogenesis by AP2-G. Parasitol Int. 2021;84:102403. doi: 10.1016/j.parint.2021.102403 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref085] 85.Abdelraheem MH, Bansal D, Idris MA, Mukhtar MM, Hamid MMA, Imam ZS, et al. Genetic diversity and transmissibility of imported Plasmodium vivax in Qatar and three countries of origin. Sci Rep. 2018;8(1):8870. doi: 10.1038/s41598-018-27229-z [DOI] [PMC free article] [PubMed] [Google Scholar]

[pntd.0011926.ref086] 86.Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12(12):833–40. doi: 10.1038/nrmicro3364 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref087] 87.Hofmann NE, Gruenberg M, Nate E, Ura A, Rodriguez-Rodriguez D, Salib M, et al. Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study. Lancet Infect Dis. 2018;18(10):1108–16. doi: 10.1016/S1473-3099(18)30411-0 [DOI] [PubMed] [Google Scholar]

[pntd.0011926.ref088] 88.Kosasih A, Koepfli C, Dahlan MS, Hawley WA, Baird JK, Mueller I, et al. Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study. Malar J. 2021;20(1):177. doi: 10.1186/s12936-021-03709-y [DOI] [PMC free article] [PubMed] [Google Scholar]

PERMALINK

Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms

Daniel Kepple

Colby T Ford

Jonathan Williams

Beka Abagero

Shaoyu Li

Jean Popovici

Delenasaw Yewhalaw

Eugenia Lo

Roles

Abstract

Author summary

1. Introduction

2. Materials and methods

2.1 Ethics statement

2.2 Sample preparation

2.3 Data analyses

2.4 Comparison of datasets

3. Results

3.1 Overview of the Ethiopian P. vivax transcriptomes

Fig 1.

Fig 2.

3.2 Top 30 transcripts of Ethiopian P. vivax

Fig 3. Heat map showing the top 30 highly transcribed genes based on log(2)CPM+1.

3.3 Differentially expressed genes among geographical P. vivax

Fig 4.

3.4 Expression of genes related to erythrocyte invasion

Fig 5. Heatmap showing 43 genes associated with erythrocyte binding function in the Ethiopian P. vivax based on log(2)TPM+1 values.

Fig 6.

3.5 Expression of female and male gametocyte genes

Fig 7. Heatmap comparing 26 P. vivax gametocyte biomarker candidates across the Ethiopian, Cambodian, and Brazilian P. vivax.

4. Discussion

5. Conclusion

Supporting information

Acknowledgments

Data Availability

Funding Statement

References

Decision Letter 0

Ananias A Escalante

Walderez O Dutra

Roles

Author response to Decision Letter 0

Decision Letter 1

Walderez O Dutra

Roles

Acceptance letter

Walderez O Dutra

Roles

Associated Data

Supplementary Materials

Data Availability Statement

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases